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Background: Pleural fibrosis and malignant mesotheliomas (MM) occur after exposures to pathogenic fibers, yet
the mechanisms initiating these diseases are unclear.
Results: We document priming and activation of the NLRP3 inflammasome in human mesothelial cells by asbestos
and erionite that is causally related to release of IL-1β, IL-6, IL-8, and Vascular Endothelial Growth Factor (VEGF).
Transcription and release of these proteins are inhibited in vitro using Anakinra, an IL-1 receptor antagonist that
reduces these cytokines in a human peritoneal MM mouse xenograft model.
Conclusions: These novel data show that asbestos-induced priming and activation of the NLRP3 inflammasome
triggers an autocrine feedback loop modulated via the IL-1 receptor in mesothelial cell type targeted in pleural
infection, fibrosis, and carcinogenesis.
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Human mesothelial cells (HMC) possessing phenotypic
and functional features of both epithelial cells and fibro-
blasts are unique cell types lining the pleural (lung),
peritoneal and pericardial cavities. They are target cells
of asbestos-associated malignant mesothelioma (MM),
unique and devastating tumor types with a poor progno-
sis. For example, the average life span of patients with
MM is approximately 12 months after diagnosis, despite
a number of therapeutic strategies (reviewed in [1-3]).
The incidence of MM is increasing worldwide, especially
in third world countries where use of asbestos is largely
unregulated; thus MM remains a global health problem.
In addition, abnormal function of mesothelial cells is
intrinsic to the development of pleural effusions after
infection or pleural injury and pleural fibrosis, an* Correspondence: Arti.Shukla@uvm.edu
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reproduction in any medium, provided the orasbestos-associated disease with no effective treatment
options [4].
Mechanisms of pulmonary injury that contribute to
the development of pulmonary fibrosis (asbestosis) by
asbestos fibers have been studied for decades in clinical
and experimental studies (reviewed in [5,6]). The hallmarks
of asbestos inhalation in humans and rodents include early
and sustained inflammation causally attributed to initial
accumulation of alveolar macrophages that attempt to
engulf asbestos fibers, participate in mucociliary clearance
of fibers from the lung, and transport fibers to lymph
nodes or the lung interstitium. A number of studies have
focused on chemotactic factors and cytokine/chemokine
release by alveolar macrophages that are essential to
neutrophil influx, macrophage-epithelial or macrophage-
fibroblast signaling, and the development of epithelial cell
hyperplasia and fibrosis. We initially reported mechanisms
of activation of the Nod-like receptor-family protein 3
(NLRP3, NALP3) inflammasome and IL-1β production by
asbestos fibers in human macrophage-like cells (THP-1
line) and monocytes in vitro [7]. These data support aal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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inflammatory, carcinogenic and fibrogenic than shorter
fibers in rodents (reviewed in [5,6,8]), elicited reactive
oxygen species through iron-driven redox reactions on the
fiber surface as well as by prolonged NADPH oxidase
stimulation during frustrated phagocytosis of fibers. Use
of NLRP3 knock-out mice showed that the inflammasome
was linked functionally to pulmonary inflammation and
elevations in IL-1β and KC, a potent neutrophil chemo-
attractant, in bronchoalveolar lavage fluids. Moreover,
NLRP3 knockout mice were more resistant to asbestos-
induced lung injury. Subsequently, inflammasome acti-
vation by a myriad of endogenous and exogenous
stress-associated danger signals (DAMPs), including in-
fectious and toxic agents, has been intensely studied in
myeloid cells and very little in non-myeloid cells. This
work has generally focused on modulation of the
immune system, properties and mechanisms of agents
affecting inflammasome activation, and signaling path-
ways/receptors involved (reviewed in [9,10]).
Although macrophages play critical roles in clearance
as well as inflammation and cell signaling in response to
pathogenic fibers in the airways and interstitium of the
lung, little is known about whether or not they are re-
quired for translocation of asbestos fibers to the pleura
or are essential for pleural inflammation and genesis of
pleural diseases (reviewed in [8]). For example, accumu-
lation of fibers in localized acellular areas (pleural
plaques) is observed on the pleural surface as opposed
to fiber-laden alveolar macrophages and asbestos bodies
(iron-coated fibers linked to accumulation and death of
macrophages) in the lung [1,5,6,8].
Here we tested the hypothesis that activation of the
NLRP3 inflammasome occurs in human mesothelial
cells after pleural injury and is linked causally to release
of critical cytokines associated with the development of
inflammation and pleural diseases. First, we show that
in vitro exposures to the naturally occurring, mineral-
ogically distinct fibers crocidolite asbestos and erionite
(a fiber type linked to epidemic proportions of MM in
areas of Turkey) [11], cause increases in transcription of
NLRP3 mRNA and release of mature IL-1β that are
inhibited using NLRP3 siRNA. These changes were ac-
companied by increases in caspase-1 activity. Elevations
in steady-state mRNA levels of NLRP3, IL-1β, IL-6 and
IL-8, and release of IL-1β, IL-6, IL-8 and VEGF by HMC
were causally linked to an autocrine pathway that was
inhibited after addition of the IL-1 receptor antagonist
(IL-1ra), Anakinra. In addition, we demonstrate that
fiber-exposed HMC cells release the alarmin, HMGB1,
via a NLRP3-dependent pathway that is abrogated by
blocking the IL-1 receptor (IL-1r). Lastly, we used a
well-characterized human xenograft model of peritoneal
MM [12] to show early (1 and 4 wks) production ofcritical cytokines in peritoneal lavage fluid (PLF) by hu-
man MM prior to tumor establishment. Cytokines (IL-8,
VEGF, IL-6) in PLF were inhibited most markedly at 1
wk after intraperitoneal (IP) injection of Anakinra in the
absence of changes in numbers of macrophages, neutro-
phils or lymphocytes. Our studies highlight the func-
tional importance of inflammasome-mediated cytokine
production via an autocrine pathway in HMC that is
perpetuated by durable pathogenic fibers in the pleura.
Moreover, data reveal that mesothelial cells are pluripo-
tent cells responding to fiber-induced NLRP3 activation
by producing inflammasome-associated pro-inflammatory
and angiogenic cytokines via an autocrine feedback loop.
We did not observe a significant reduction in spheroid/
tumor volume after 4-wks of once daily Anakinra treat-
ment. This may be due to the fact that Anakinra has very
short half-life in mice. Future experiments might require a
constant infusion of Anakinra for it to become effective.
Taken together, our in vitro and in vivo results suggest
that selective targeting of the NLRP3 inflammasome or
IL-1r may be critical in the prevention and therapy of
asbestos-induced pleural diseases.
Results
Asbestos causes NLRP3 priming and activation in human
mesothelial cells
Crocidolite asbestos (Na2O · Fe2O3 · FeO · 8SiO2 · H2O) is
considered to be the most pathogenic of the several as-
bestos types in the induction of MM [1,2]. To determine
if HMC expressed the NLRP3 inflammasome and
whether its transcription occurred selectively in response
to pathogenic fibers, we first exposed the LP9-TERT-1
(LP9) HMC line to crocidolite asbestos in a dose–
response experiment over a 24 h period, i.e., the time
necessary for precipitation of fibers on cells. The soluble
tumor promoter, 12-O-tetraoctodecanol phorbol-3 acetate
(TPA) (added for 1 h) was included as a positive control,
and amorphous glass beads (GB) as a non-pathogenic par-
ticle control. In comparison to untreated control cells,
both asbestos and TPA caused increased expression of
NLRP3 mRNA in contrast to GB (Figure 1B). Increased
transcription of NLRP3 by asbestos was protracted
(Figure 1C), an observation of direct relevance to mech-
anisms of action of durable, pathogenic fibers in the lung
and pleura over time. NLRP3 protein was also increased by
asbestos exposure (Figure 1E). We then measured caspase-
1 activity, an inflammasome-activation phenomenon linked
to processing of mature IL-1β in HMC in the presence and
absence of asbestos fibers (Figure 1D). These studies re-
vealed that caspase-1 activity was significantly elevated
(p ≤ 0.05) by asbestos as measured by activity assay and
Western blot analysis to show p20 release in supernatant
(medium) (Figure 1F). A consequence of inflammasome
activation is release of mature IL-1β, produced as an
Figure 1 (See legend on next page.)
Hillegass et al. Particle and Fibre Toxicology 2013, 10:39 Page 3 of 14
http://www.particleandfibretoxicology.com/content/10/1/39
(See figure on previous page.)
Figure 1 Asbestos primes and activates NLRP3 in HMC. (A) Crocidolite asbestos fibers (arrows in left panel) and GB (arrows in right panel)
interact with differentiated LP9 mesothelial cells that are characterized by long microvilli both in vivo and in vitro. Bars = 10 μm. (B) Crocidolite
asbestos (Asb) and the soluble tumor promoter, TPA cause increased trends in NLRP3 mRNA levels, as demonstrated by qRT-PCR. In contrast,
non-pathogenic GB at identical SA concentrations have no effects (N = 2 samples/group/time point; N = 3 for control, 8 + 24 h (0) group). (C) A
time course study shows the protracted nature of NLRP3 transcription by asbestos (75) (N = 2 samples/group/time point; N = 4 for control (0)).
(D) Caspase-1 activity is significantly increased by asbestos (75) at 24 and 48 h (N = 4 samples/group/time point; combined data from two
experiments). A randomized block ANOVA was used to determine significance for this experiment. * = significantly different p≤ 0.05) from
untreated control group (0). (E) Asbestos-induced NLRP3 protein levels in HMC. (F) Western blot analysis of secreted p20 subunit of caspase-1 (an
indicator of caspase-1 activation) in medium in response to asbestos exposure in HMC (N = 2 samples/group/time point). (G) HMGB1 release in
medium from HMC cells in response to asbestos exposure. (H) IL-1β released into the medium of HMC in response to asbestos exposure as
measured by ELISA, and IL-18 (I) released over time as measured by ELISA (N = 2 samples/group/time point). * = significantly different (p ≤ 0.05)
from 0 control at same time point; † = significantly different (p ≤ 0.05) from 8 h asbestos group.
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by caspase-1. IL-1β is a critical protein facilitating inflam-
mation, production of other pro-inflammatory cytokines,
and mesothelial cell transformation (reviewed in [9,10,13]).
In Figure 1H, we show dramatic release of IL-1β over time
by asbestos in LP9 mesothelial cells. In addition, we show
increased levels of HMGB1, and IL-18 release in the
medium from asbestos-exposed cells (Figure 1G,I). As the
ELISA kits used for IL-1β and IL-18 detection detect pre-
dominantly mature forms, we assume that asbestos-
induced NLRP3 activation is processing these two cyto-
kines and mature form is being detected in medium. These
studies in concert show that protracted NLRP3 transcrip-
tion by asbestos is accompanied by caspase-1 activation.
Moreover, transcription is selectively induced by a fibrous
(asbestos) or soluble tumor promoter (TPA) and not by
inert particles (GB). Both asbestos and GB interacted with
and were taken up by HMC in vitro (Figure 1A). To con-
firm that increased NLRP3 mRNA levels after asbestos ex-
posure were due to transcriptional regulation, we pre-
treated LP9 cells with Actinomycin D (Act D) that
abolished these elevations (Additional file 1: Figure S1A).
Next we validated our findings on inflammasome priming
and activation by asbestos in human primary peritoneal
mesothelial cells (HM3). Additional file 1: Figure S1B
shows that like immortalized human mesothelial cells
(LP9), asbestos fibers also prime and activate NLRP3 in
HM3 cells. Primary peritoneal HM3 mesothelial cells also
demonstrate significant secretion of IL-1β in response to
asbestos exposure (Additional file 1: Figure S1C).We also
assessed the effect of asbestos on other inflammasomes
NLRP1 and Absent in Melanoma 2 (AIM2) and on
PYCARD/ASC and found no significant effect (data not
shown).
Asbestos causes other cytokine release from
mesothelial cells
To confirm and determine whether IL-1β and other cy-
tokines were released in both LP9 and NYU474 primary
pleural HMC, we performed Bio-Plex cytokine assays on
medium from these cells (24 h after asbestos exposure).Tumor Necrosis Factor-α (TNFα) was added to some
groups to determine whether or not it was a necessary
factor for asbestos-induced cytokine release. The ration-
ale for these studies is that TNFα is mitogenic to meso-
thelial cells [14], causes MM cell transformation [13],
and may have pleiomorphic effects on inflammation
and/or cell defense as it is linked to both upregulation of
the mitochondrial antioxidant enzyme, manganese-con-
taining superoxide dismutase (SOD2) [15], as well as
increased chemokine production by lung macrophages
and neutrophils after pathogenic particle exposures [16].
Similar trends of IL-1β release from LP9 and NYU474
HMC were observed in that addition of either TNFα
(10 ng/mL) or asbestos alone at non-toxic or lytic (15 vs.
75 × 106 μm2/cm2) surface area (SA) concentrations
[17], significantly (p ≤ 0.05) increased IL-1β levels in
medium (Figure 2A). These experiments also revealed
that TNFα and high dose of asbestos acted synergistic-
ally on IL-1β release from LP9 cells (The differences in
levels of IL-1β detected in two different experiments,
Figures 1H and 2A, could be attributed to different tech-
niques (ELISA kit and Bio-Plex cytokine assay) used for
assessment). The important point is asbestos exposure
causes significant increases in IL-1β secretion from
mesothelial cells. In LP9 mesothelial cells, significantly
(p ≤ 0.05) increased IL-6 levels were observed after
addition of asbestos or TNFα alone, and dramatic syn-
ergy was observed with use of both agents, especially at
the higher concentration of asbestos (75) (Figure 2B).
Levels of IL-1ra produced in medium by mesothelial
cells were increased significantly only in cells exposed
to both asbestos and TNFα (Figure 2C). In contrast,
TNFα had no effect on HMGB1 release from LP9 cells
(Figure 2D) and TNFα and asbestos together did not pro-
duce a synergistic effect on HMGB1 release (Figure 2D).
To determine whether NLRP3 activation was causally
related to release of IL-1β, confirming an inflammasome-
activated pathway in HMC, downregulation of NLRP3
was verified in siNLRP3- transfected LP9 cells in contrast
to cells transfected with scrambled control siRNA (siCon)
(Figure 3A). Protein levels of NLRP3 showed significant
Figure 2 Asbestos and TNFα causes release of cytokines from HMC. The LP9 cell line and isolated pleural mesothelial (NYU474) cells in
culture were exposed to asbestos in the presence (+) or absence (0) of TNFα. (A) Release of IL-1β in the presence and absence of TNFα. (B) Levels of
IL-6 in medium. IL-6 levels in NYU474 cells were elevated and above the scale of detection for LP9 cells. (C) Levels of IL-1ra in medium. All experiments
in A-C were performed using a Bio-Plex protein array system for 27 human cytokines on media supernatants collected after 24 h of exposure to
agents (N = 3 samples/group). Levels of IL-8 in groups of NYU474 and LP9 cells were higher than the standard curve of detection. (D) TNF priming did
not increase asbestos-induced HMGB1 release from LP9 cells at 48 h (N = 3 samples/group/timepoint). * = significantly different (p≤ 0.05) from
untreated control group (0); † = significantly different (p≤ 0.05) from TNFα-treated group; ‡ = significantly different (p≤ 0.05) from asbestos alone
group at the same concentration.
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turnover rate of NLRP3 protein in LP9 cells (Figure 3B).
This approach also showed that asbestos-induced in-
creases in IL-1β and HMGB1 were decreased significantly
(p ≤ 0.05) in siNLRP3-transfectants (Figure 3C,D). Inhib-
ition of NLRP3 also attenuated priming effect of TNFα
and asbestos on IL-1β (Figure 3E). However, knock-down
of NLRP3 did not affect asbestos-induced cell death (data
not shown).
NLRP3 activation by erionite
Here we tested the hypothesis that erionite fibers primed
and activated the inflammasome. First, we performed
dose–response toxicity studies in LP9 cells to find that
erionite fibers over a range of SA concentrations as high
as 300 × 106 μm2/cm2 were non-toxic to cells over a
72 h period. This lack of cell death at high concentra-
tions of fibers contrasted markedly with the toxicity of
crocidolite asbestos at 75 × 106 μm2/cm2 (Additional file
2: Figure S2C). These data support previous reports
showing that erionite fibers are more mesotheliomagenic
than asbestos because progenitor cells of MM are not
killed by erionite fibers. A subsequent toxicity study with
erionite revealed that concentrations as high as 1,200 ×
106 μm2/cm2 resulted in significant (p ≤ 0.05) decreasesin cell numbers at 24 h that did not increase over a time
period of 72 h (Additional file 2: Figure S2D). As shown
in Figure 4A-C, erionite at both non-toxic (300) and
toxic (1,200) amounts caused dose-related increases in
steady-state mRNA levels of NLRP3 and IL-1β, but not
the adapter-interacting protein (ASC/PYCARD), a com-
ponent of the multi-protein inflammasome platform.
Caspase-1 activity was elevated significantly by erionite
(1,200) at 72 h (Figure 4D), whereas dose-related in-
creases in release of IL-1β were observed by erionite at
300 and 1,200 SA concentrations (Figure 4E). The resist-
ance of mesothelial cells to erionite-induced toxicity and
erionite’s ability to cause activation of the NLRP3
inflammasome as well as production of IL-1β and other
cytokines at non-toxic concentrations may be of mechan-
istic significance to promulgation of erionite-transformed
cells and its increased potency in MM carcinogenesis.
HMGB1 is a putative biomarker of inflammation in a
number of diseases including endotoxemia, cystic fibro-
sis, and some tumors including MM [18-20]. In the pres-
ence of IL-1β or TNFα, this nuclear protein is released
into the cell cytoplasm or secreted. Once extracellular,
HMGB1 binds to a number of cytokine proteins that con-
fer increased pro-inflammatory activity [21]. To determine
whether erionite caused increased intracellular levels of
Figure 3 NLRP3 inhibition attenuates IL-1β and HMGB1 release from HMC. (A) Inhibition of NLRP3 using siNLRP3 in LP9 cells significantly
inhibits siNLRP3 mRNA levels (* = p≤ 0.05 as compared to siCon group) and (B) Inhibition of NLRP3 using siNLRP3 in LP9 cells significantly attenuated
NLRP3 protein levels at 78 h. (C) Production of mature IL-1β, (* = p≤ 0.05 as compared to untreated siCon cells; † = p≤ 0.05 as compared to siCon
asbestos-exposed group). (D) Crocidolite asbestos increases HMGB1 release that is blocked in siNLRP3-transfected cells at 24 h (N = 3 samples/group).
* = significantly different (p≤ 0.05) when compared to siCon group; † = significantly different (p≤ 0.05) when compared to siCon asbestos-exposed
group. Priming effect of TNFα on IL-1β was blocked by siNLRP3 at 48 h (E) (N = 2, 4 for asbestos alone groups, * = significantly different (p≤ 0.05) from
siCon untreated (0) group).
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masome-dependent process, LP9 cells were exposed to
erionite (SA = 300, 1,200). These studies revealed that al-
though increases in intracellular levels of HMGB1 were
not observed at 8 or 24 h by erionite (Figure 4F), toxic
concentrations of erionite (1,200) caused significantly ele-
vated levels of HMGB1 in medium (Figure 4G). This find-
ing suggests that although erionite does not increase the
expression of HMGB1, it does alter its release from cells.
Anakinra alters cytokine transcription
We next hypothesized that transcription and release of
IL-1β (and possibly other cytokines linked to interaction
of IL-1β or IL-1α with the IL-1 receptor) would be al-
tered after pre-addition of Anakinra (Ana) to HMCs.After performing a series of dose–response studies with
Anakinra in vitro and in vivo at concentrations used by
others [22,23], we performed studies using Anakinra at
100 ng/mL, a non-toxic dose causing significant de-
creases in elevated mRNA levels of NLRP3, IL-1β, IL-6
and IL-8 observed at both low and high concentrations
of asbestos (Figure 5A,B). Next we evaluated whether
Anakinra pre-treatment significantly inhibited release of
asbestos-induced IL-1β, IL-6, granulocyte-colony stimu-
lating factor (G-CSF) [24], VEGF and HMGB1. In most
cases, asbestos-exposed cells showed levels of cytokines
in medium that were lower (p ≤ 0.05) after pre-addition
of Anakinra (Figure 5C-G). These results suggest that an
autocrine pathway exists in mesothelial cells whereby
blocking of the IL-1 receptor renders less transcriptional
Figure 4 NLRP3 priming and activation by erionite in HMC. Human mesothelial cells (LP9) exposed to erionite in vitro show dose-related
increases in steady-state mRNA levels of NLRP3, (A) and IL-1β, (B) but not ASC/PYCARD (C). Increases in caspase-1 activity (D) and IL-1β release
(E) also are observed by erionite at high concentrations (SA = 1,200 μm2/cm2 dish) (N = 3 samples/group/time point). * = significantly different
(p ≤ 0.05) from untreated control group (0) at same time point; † = significantly different (p ≤ 0.05) from respective erionite-exposed group at
24 h. Lack of intracellular accumulation of HMGB1 in response to erionite (F) supports rapid dose-related increases in release by erionite as
measured by Western blot analyses on cell medium (G) (N = 2 samples/group/time point). * = significantly different (p ≤ 0.05) as compared to
untreated control group (0) at the same time point.
Hillegass et al. Particle and Fibre Toxicology 2013, 10:39 Page 7 of 14
http://www.particleandfibretoxicology.com/content/10/1/39upregulation of asbestos-induced NLRP3 and NLRP3-
regulated cytokines as well as their production and re-
lease by cells.
Anakinra alters cytokines in PLF of SCID mice
As a next relevant step in demonstrating the ramifica-
tions of this feedback loop in a model of peritoneal MM,
we determined whether injection of Ana blocked pro-inflammatory cytokine and VEGF levels in PLF from
severe combined immunodeficient (SCID) mice after in-
jection of human H2373 MM cells. These mice are ideal
for our studies as they have normal macrophages and
neutrophils, but are deficient in lymphocyte function
which permits human MM establishment. In this model,
early increases in IL-6, IL-8 and VEGF in lavage fluids
are produced by both epithelioid and sarcomatoid MM
Figure 5 Anakinra inhibits asbestos-induced NLRP3 and interleukin mRNA levels and secretion of cytokines in medium. Use of the IL-1ra,
Ana (100 ng/mL), decreases asbestos-induced (A, B)mRNA levels of NLRP3 and IL-1β, IL-6, and IL-8 at 24 h, as quantitated by qRT-PCR (N = 3 samples/
group/time point). * = significantly different (p≤ 0.05) when compared to untreated control group (0); † = significantly different (p≤ 0.05) when
compared to asbestos group alone. Asbestos-induced secretion of IL-1β (C) IL-6 (D) G-CSF (E) and VEGF (F) were measured in LP9 cells at 24 h using a
human IL-1β ELISA kit (C) or a human cytokine Bio-Plex assay (D-F) in the presence and absence of Ana (Ana = 100 ng/mL). Levels of HMGB1 (G) were
determined by Western blot analysis (N = 3 samples/group). * = significantly different (p≤ 0.05) when compared to untreated cells (0); † = significantly
different (p≤ 0.05) when compared to groups exposed to asbestos alone.
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opment [12]. Ana (100 mg/kg) was administered to mice
receiving saline alone (no tumor cells) and immediately
following MM cell injection in saline. PLF was collected
from these and control groups not receiving Ana at 1
and 4 wks for detection of human cytokines and total
and differential cell counts. As presented in Figure 6A,
Ana significantly (p ≤ 0.05) reduced levels of IL-8 and
VEGF in PLF at 1 wk. At 4 wks, mice injected with Ana
showed trends in inhibition of IL-6 and IL-8 levels; how-
ever, differences did not reach statistical significance be-
cause of large variability in the MM group not receivingAna. Likewise, no significant decreases in VEGF or IL-8
levels by Ana were observed at this later time point, pre-
sumably because of overwhelmingly (approximately 4
and 7-fold, respectively) increased production of these
factors by human MM from 1 to 4 wks (no significant
differences in IL-1β levels at any time point in any group
were observed, 4 wks data not shown). Total and differ-
ential cell counts in PLF revealed no significant differ-
ences in numbers of macrophages, neutrophils or
lymphocytes between Ana-treated and non-Ana-treated
mice at either time point, although increased neutrophils
were observed in all MM-injected mice at 4 wks as
Figure 6 (See legend on next page.)
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Figure 6 Anakinra inhibits MM-induced cytokines in PLF of SCID mice. (A) at 1 wk, N = 3 samples/group; at 4 wks, N = 5–6 samples/group).
* = significantly different (p ≤ 0.05) when compared to respective groups receiving no Anakinra; † = significantly different (p ≤ 0.05) when
compared to respective saline (no tumor cell) groups. Left panels at 1 and 4 wks verify activity of Anakinra, an IL-1ra, in respective treatment
groups. Use of a Bio-Plex panel for mouse cytokines on the same PLF samples failed to reveal any significant changes [12]. (B) Lack of changes in
macrophages, neutrophils and lymphocyte numbers and proportions at 1 and 4 wks suggests the absence of involvement of cells of the
immune system in cytokine release and inflammation. † = significantly different (p≤ 0.05) when compared to respective saline (no Ana) groups.
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inflammatory responses in all groups suggests that MM
cells may not require cells of the immune system for
cytokine release and inflammation.
Discussion
Most research on the role of inflammation in asbestos-
associated diseases has focused on macrophages, as this
is the first cell type accumulating in the lung at sites of
initial deposition of inhaled asbestos fibers. In addition,
the vast majority of published studies with few excep-
tions [25] exploring the role of inflammasomes in the de-
velopment of a number of diseases have been performed
in macrophages or monocytes. Erionite, a non-asbestos
fiber type of the zeolite mineral group, is morphologic-
ally similar to crocidolite asbestos (Additional file 2:
Figure S2A, B), but is more potent in the causation of
MM in rodents [26] and is of contemporary concern
because of the high prevalence of MM observed in
areas of Turkey where erionite fibers exist in soils and
homes [11,27]. The uniqueness of work here is the
demonstration that the pathogenic fibers, asbestos and
erionite, but not innocuous particles, such as glass
beads, cause both priming and activation of the NLRP3
inflammasome in human mesothelial cells, responses
that trigger transcription and production of cytokines
critical to the initiation of pleural injury and infection,
MM and pleural fibrosis. These responses were va-
lidated in primary human pleural and peritoneal
mesothelial cells. Most importantly, we link NLRP3
activation to the release of several pro-inflammatory
cytokines and VEGF by fiber-stimulated human meso-
thelial cells in vitro. As these factors are identical to
those produced from human MM during the initial
stages of inflammation in a SCID mouse MM xeno-
graft model, we believe that IL-1β may be responsible
for MM tumor progression also in absence of asbestos
fibers. Our studies support a model where an autocrine
loop in human mesothelial cells is perpetrated by fiber-
induced NLRP3 priming and activation and increased
transcription of IL-1β, IL-6 and IL-8 (Additional file 2:
Figure S2E). Under these circumstances, HMGB1 may
bind to these cytokines, thus increasing its pro-inflam-
matory properties [21] and be exuded into serum after
injury to the pleura. In support of our findings Yang
et al. [20] have previously shown the release of HMGB1from asbestos-exposed mesothelial cells, however, we
are first to link the asbestos-induced HMGB1 release
and NLRP3. Findings of Yang et al. link HMGB1 release
as a critical first step in the pathogenesis of asbestos-
associated diseases. Both NF-κB and mitogen-activated
protein kinase signaling have been implicated as mecha-
nisms regulating the transcription of pro-IL-1β [28], and
asbestos activates both of these pathways in mesothelial
cells [29-31]. Transcription and production of IL-1β may
be key to induction of VEGF gene expression at both
transcriptional and post-transcriptional levels [32] as
well as IL-6 and IL-8 expression [33]. IL-6 also induces
VEGF production through a JAK2/STAT3 pathway [34]
and can modulate production of IL-1β in a JAK2-
dependent manner [35]. Thus, other pathways of syn-
ergy and interaction between these factors may exist in
HMC in addition to increased expression and release of
these cytokines via inflammasome and caspase-1 activa-
tion [36].
The main purpose of our study here is to demonstrate
that stimulation of the IL-1 receptor may be essential for
cytokine induction (via an autocrine loop) by asbestos-
exposed mesothelial cells in initiation of MM (in vitro
studies) as well as in MM tumor progression (in vivo
studies). Our in vitro studies show that mesothelial cells
secrete IL-1β in response to asbestos/erionite which can
then affect the same population of mesothelial cells in
an autocrine manner, thus transforming them to become
mesothelioma cells. Our in vivo model on the other
hand demonstrates that MMs generated from mesothe-
lial cells after asbestos exposures can further secrete IL-
1β and/or be affected by IL-1β secreted by host cells,
thus affecting their growth/progression (in the absence
of asbestos). Therefore, blocking the IL-1 receptor
in vivo could be helpful in attenuation of MM growth
and progression.
An exciting observation in both in vitro studies and
our human MM xenograft model of inflammation was
that levels of interleukins and VEGF were blocked using
the IL-1r antagonist, Anakinra, currently used for clin-
ical treatment of various inflammatory diseases, includ-
ing Muckle-Wells syndrome [37], gout [38], and arthritis
[39]. The lack of significant effects of Anakinra on IL-6,
IL-8 and VEGF levels at 4-weeks (Figure 6) could be
attributed to two reasons: 1) overwhelming increases in
levels of VEGF (4 fold) and IL-8 (7 fold) at 4-weeks;
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Future experiments will include repeated dosing or
constant infusion of Anakinra to produce significant
effects. Our results suggest an autocrine feedback loop
resulting in cytokine release that can be blocked at the
IL-1 receptor in mesothelial cells. In addition to abro-
gating the inflammatory mechanisms of mature IL-1β
that may also orchestrate the expression, production,
and effects of IL-6, IL-8 and VEGF, this approach may
be valuable in preventing the ramifications of robust
production and release of IL-1 from necrotic and
neighboring mesothelial cells after infection [40] or ex-
posure to asbestos fibers. IL-1α is a key danger signal
that triggers both CXCL1 secretion and recruitment of
neutrophils via interaction with the IL-1 receptor in
murine mesothelial cells [40]. The fact that Anakinra is
non-toxic after repeated administration to mice or
humans [23] suggests its use as a novel approach in
prevention and treatment of inflammation, a common
feature of pleural infection and disease.
Conclusions
In summary, data here question the popular paradigm
that initiation of pleural diseases by pathogenic fibers re-
quires cells of the immune system. Moreover, they reveal
that unlike macrophages and monocytes, and like
MSTO-211H human mesothelioma cells [25], human
mesothelial cells do not require exogenous TNFα or
lipopolysaccharide to initiate NLRP3-mediated cytokine
release. Conversely, exposure to pathogenic fibers both




LP9/TERT-1 (LP9), an hTERT-immortalized cell line
that functionally resembles normal human peritoneal
mesothelial cells [41] and human primary peritoneal
mesothelial cells (HM3) were obtained from Dr. James
Rheinwald (Brigham and Women’s Hospital, Harvard
University, Boston, MA). Human pleural mesothelial cells
(NYU474) were isolated surgically from cancer-free pa-
tients by Dr. Harvey I. Pass (New York University, New
York, NY), as was the H2373 sarcomatoid MM cell line
[42]. The H2373 MM line gives rise to biphasic MM
after injection into SCID mice as verified by a board-
certified pathologist (Dr. Kelly Butnor at UVM) [12].
LP9 and H2373 cells were cultured as described previ-
ously [17]. NYU474 cells were grown to near confluence
in DMEM containing 10% FBS and supplemented with
penicillin (50 units/mL) and streptomycin (100 μg/mL).
HM3 cells were grown in 50:50 M199:MCDB106 medium
(Invitrogen, Carlsbad, CA) supplemented with 15% FBS,
10 ng/mL EGF, 0.4 μg/mL hydrocortisone, 50 units/mLpenicillin and 100 μg/mL streptomycin. All cells were in-
cubated at 37°C in 5% CO2 and grown to 80-90% conflu-
ence before addition of agents.
Sources of crocidolite asbestos, erionite and glass beads
The physical and chemical characterization of the
NIEHS reference sample of crocidolite asbestos has
been reported previously [43]. Erionite fibers from Pine
Valley, NV, were provided and characterized using simi-
lar methods by Dr. Ian Steele (University of Chicago,
Chicago, IL). The SA of asbestos and erionite fibers and
GB (Polysciences Inc., Warrington, PA) was measured
using nitrogen gas sorption analysis. Asbestos, erionite
fibers and glass beads were exposed to UV light over-
night to inactivate any pathogens growing on them be-
fore adding to cell culture.
Scanning electron microscopy (SEM)
Cells grown on Thermonox coverslips (Nalge Nunc
International, Naperville, IL) were fixed for imaging as
previously described [17], and critical point-dried using
liquid CO2 as the transition fluid in a Samdri PVT-3B
critical point dryer (Tousimis Research Corporation,
Rockville, MD). Cells on coverslips and fibers on carbon
tape were then mounted on aluminum specimen stubs
and dried before being sputter-coated with gold and pal-
ladium in a Polaron sputter coater (Model 5100;
Quorum Technologies, Guelph, ON, Canada) and exam-
ined using a JSM 6060 scanning electron microscope
(JEOL USA, Inc., Peabody, MA).
Viability studies
Following sterilization under ultraviolet light overnight
to destroy lipopolysaccharide or microbial contami-
nants, minerals were suspended in 1 X Hanks’ Balanced
Salt Solution (HBSS) at 1 mg/mL, sonicated for 15 min
in a water bath sonicator, and triturated 5 X through a
22-gauge needle. This suspension was added to cells in
medium to achieve the desired SA-based concentrations.
After 24 h intervals, cells were collected by trypsinization,
and counted using a hemocytometer [17].
Quantitative Real-Time PCR (qRT-PCR)
Total RNA (1 μg) was reverse-transcribed with random
primers using the Promega AMV Reverse Transcriptase
kit (Promega, Madison, WI) according to the recom-
mendations of the manufacturer as described previously
[17]. Transcription was evaluated using the ΔΔCt
method. Duplicate or triplicate assays were performed
with RNA samples isolated from at least two independ-
ent experiments. The values obtained from cDNAs and
hypoxanthine phosphoribosyl transferase (hprt) controls
provided relative gene expression levels for the gene
Hillegass et al. Particle and Fibre Toxicology 2013, 10:39 Page 12 of 14
http://www.particleandfibretoxicology.com/content/10/1/39locus investigated. The primers and probes used were
purchased from Applied Biosystems (Foster City, CA).
Western blot analysis for NLRP3, activated Caspase-1 p20
and HMGB1 in whole cell lysates and supernatants
(medium) of asbestos-exposed mesothelial cells
Medium was collected, cells were lysed as previously de-
scribed [44], and protein content in cell lysates was de-
termined using the RC DC protein assay (Bio-Rad,
Hercules, CA). Medium (500 μL) was concentrated
using Amcion® ultracentrifugal filters with a 10 K mem-
brane (Millipore, Billerica, MA) by spinning at 14,000 X
g for 30 min. Columns were then reversed into new col-
lection tubes and spun for 2 min at 1,000 X g. Sample
buffer was added to the concentrated supernatant, and
samples were boiled for 15 min. Western blots were
performed as previously described [44] on both cell ly-
sates (NLRP3, HMGB1) and concentrated supernatants
(HMGB1, Capase1-p20). Rabbit polyclonal antibodies
for HMGB1 (Abcam, Cambridge, MA), NLRP3 (Novus
Biologicals, Littleton, CO) and Caspase-1-p20 (Cell
Signaling, Danvers, MA) were used at 1:500 dilutions.
Caspase-1 activity assay
Caspase-1 activity was measured using the Caspase-1
Colorimetric Assay (R&D Systems, Minneapolis, MN),
according to the manufacturer’s directions. Caspase-1
activity was determined as OD405 (after subtraction of a
blank control) relative to total protein. Protein concen-
trations were determined by the Bio-Rad protein assay
[45] using the remaining lysate.
ELISA assay for IL-1β and IL-18
The Quantikine Human IL-1β/IL-1f2 Immunoassay (R&D
Systems, Minneapolis, MN, measures predominantly ma-
ture IL-1β) was used on concentrated cell medium, pre-
pared as described earlier, and the assay performed
according to the manufacturer’s instructions. A total of
500 μL of cell supernatant was concentrated. Two hun-
dred μL samples with assay diluents were loaded into 96
well plates pre-coated with IL-1β antibody. For IL-1β re-
lease studies in erionite-exposed cells, asbestos exposed
HM3 cells and TNFα priming of siCon and siNLRP3 LP9
cells, an ELISA MAX™ Human IL-1β (Biolegend, San
Diego, CA, measures both pro and mature form) was
used. Wells were pre-coated with an IL-1β capture anti-
body overnight at 4°C. Fifty μL of concentrated samples or
standards then were prepared in assay diluent and allowed
to attach to plates overnight at 4°C. IL-18 release was
measured using the Human IL-18 ELISA kit (MBL Inter-
national, Woburn, MA, measures predominantly active
IL-18, 0.7% pro IL-18). Medium was collected (500 uL),
concentrated and processed according to the ELISA
protocol provided. Values were expressed as pg/mL ofIL-1β or IL-18 from the original supernatant (non-
concentrated).Transfection of cells with NLRP3 siRNA
On-Target plus non-targeting siRNA #1 (scrambled
control), and On-Target plus SMART pool human
NLRP3 siRNA (100 nM; Dharmacon, Lafayette, CO)
were transfected into LP9 cells at near confluence using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) follow-
ing the manufacturer’s protocol. The efficiency of
NLRP3 knockdown was determined by qRT-PCR.SCID mouse xenograft model, IP injection of human MM,
and retrieval of PLF
H2373 cells (5 × 106 cells in 50 μL 0.9% NaCl, pH 7.4)
were injected into the peritoneal cavity of 6 wk-old male
Fox Chase SCID mice (n = 3 mice/group/time point) as
described previously [12]. Mice were euthanized using
sodium pentobarbital before the peritoneal cavity of each
mouse was instilled with 5 mL of cold sterile PBS using
an 18-gauge needle. The abdomen was gently massaged,
and PLF was aspirated back into the syringe and placed
on ice. PLF was then centrifuged at 1,000 rpm for 5 min
at 4°C, and the supernatant removed and stored at −80°C
for Bio-Plex cytokine analysis. Cytospins were prepared
from cell pellets to determine total and differential cell
counts [12].Bio-Plex assays on cell medium in vitro and in PLF
To quantify cytokine and chemokine levels in cell super-
natants and PLF, a multiplex suspension protein array
was performed using a Human Cytokine 27-plex panel
(Bio-Rad) as described previously [12]. Concentrations
of each cytokine and chemokine were determined using
Bio-Plex Manager Version 3.0 software. Data were
expressed as pg cytokine/mL medium.In vitro and in vivo studies using the IL-1-ra, Ana
For in vitro experiments, cells were pre-treated with
100 ng/mL of IL-1ra Ana (Insight Genomics, Falls
Church, VA) for 1 h before administration of asbestos
[22]. For in vivo experiments, SCID mice either injected
with 500 μL sterile 0.9% NaCl (pH 7.4) or human MM
cells (H2373) in saline were then injected with 100 mg/kg
Ana (Kineret®) (Amgen, Thousand Oaks, CA) in 500 μL
sterile 0.9% NaCl (pH 7.4) [23] or 500 μL sterile 0.9%
NaCl (pH 7.4) alone. Mice were injected IP daily (with sa-
line or Ana) for 1 wk observations or 3 X IP weekly for 4
wks before euthanization and collection of PLF for Bio-
Plex cytokine analyses and cytospin preparations as de-
scribed above.
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Data were evaluated either by analysis of variance
(ANOVA) using the Student Neuman-Keul’s procedure
for adjustment of pair-wise comparisons between groups
or a Student’s t-test. Differences in gene expression
values determined by qRT-PCR were evaluated using a
Student’s t-test. Differences with p values ≤ 0.05 were
considered statistically significant. All experiments were
repeated in duplicate or triplicate. Figures represent indi-
vidual experiments, unless otherwise noted, with Mean ±
SEM presented.
Additional files
Additional file 1: Figure S1. Asbestos causes priming and activation of
NLRP3. (A) asbestos-induced increases in NLRP3 mRNA levels are
transcriptionally regulated. LP9 were treated with Actinomycin D (Act D) for
30 min before exposing them to asbestos for 24 h. Pre-treatment with Act
D resulted in inhibition of asbestos-induced NLRP3 levels. (B) HM3 cells
exposed to asbestos (75 μm2/cm2 dish) show significantly increased NLRP3
mRNA levels. (C) Increases in IL-1β and (D) HMGB1 in medium. (N = 2
samples/group/time point), N = 4 samples/control group (0) (B, C).
* = significantly different (p ≤ 0.05) when compared to untreated
control group (0); † = significantly different (p ≤ 0.05) when compared
to asbestos alone group.
Additional file 2: Figure S2. Morphology and toxicity of pathogenic
fibers. Erionite (A) and crocidolite asbestos (B) have a similar fibrous
morphology (bars = 10 μm) but are vastly different in their toxicity to LP9
human mesothelial cells (C, D) (N = 3 samples/group/time point).
Resistance of HMC cells to erionite toxicity may be one explanation for its
increased carcinogenic potential. * = significantly different (p ≤ 0.05)
when compared to untreated control group (0). (E) Schematic diagram
illustrating mechanisms of inflammasome-induced cytokine production
by asbestos and erionite in a feedback loop that is blocked by the IL-1ra,
Anakinra (Ana).
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